Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Extramammary paget disease
MeSH D010145 - extramammary paget disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000230:
Adenocarcinoma
24 Companies
3 Drugs
$
Success rate
D018299:
And medullary lobular ductal neoplasms
0 Companies
0 Drugs
Success rate
D010145:
Extramammary paget disease
45 Companies
9 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/3
Phase 3
55
%
6/11
Approved:
6
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Alendronic acid
Mylan
Alendronic acid
Organon
Alendronic acid
,
Cholecalciferol
Novartis
Pamidronic acid
,
Zoledronic acid
Merck & Co
Alendronic acid
Pfizer
Zoledronic acid
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use